Drug News
For patients with type 2 diabetes, intensive glucose control has long-term benefits for preventing end-stage kidney disease (ESKD), according to a study published online March 22 in Diabetes Care.
News
Patients with end-stage kidney disease (ESKD) undergoing maintenance dialysis express a desire to exercise to regain energy and strength, but many report barriers to exercise.
News
"We believe that the data actually suggest possible benefit for ESKD [end-stage kidney disease] with intensive glucose control, and remain inconclusive for intensive blood pressure control and fibrate use given the wide confidence intervals for the more reliable ESKD outcomes," write the authors.
Drug News
Being overweight or obese as an adolescent is significantly associated with increased risk for all-cause treated end-stage renal disease (ESRD).
Drug News
Patients with diabetes who have comorbid major depression may be at greater risk of end-stage renal disease .
Drug News
Minority race/ethnicity and lack of private insurance associated with inadequate care in U.S.
News
Excess mortality rates persist among adults with young-onset diabetes, and are mainly due to end-stage renal disease (ESRD) and coronary artery disease (CAD).
News
Dialyzed patients have higher in-hospital mortality, hemorrhagic complications after RFA for HCC
Drug News
Kidney stones correlate with an increased risk of adverse kidney outcomes, including end-stage renal disease (ESRD), Stage 3b-5 chronic kidney disease, and sustained doubling of serum creatinine, but increases in absolute rates are small.
Drug News
The lifetime risk of developing end-stage renal disease (ESRD) is higher for men than women, at all ages and estimated glomerular filtration rate (eGFR) strata.
